You must have the latest - Flash plugin - to view this slideshow. 63-year history of research and clinical excellence

Researchers identify early sign of pancreatic cancer

September 28, 2014

Scientists at Dana-Farber Cancer Institute, the Massachusetts Institute of Technology, and other institutions have discovered a sign of the early development of pancreatic cancer – an upsurge in certain amino acids that occurs before the disease is diagnosed and symptoms appear. The research is being published online today by the journal Nature Medicine.

Dana-Farber Marathon Challenge raises record $8.2 million for cancer research through 2014 Boston Marathon®
October 01, 2014

The Dana-Farber Marathon Challenge (DFMC) announced the team raised more than $8.2 million in its 25th running of the Boston Marathon® this year, the highest single-season fundraising total since the team's inception.

Novel compound prevents metastasis of multiple myeloma in mouse studies
September 25, 2014

Dana-Farber scientists and colleagues report on a compound that can stop the blood cancer multiple myeloma from spreading, leading to a new approach in addressing metastasis, one of the deadliest aspects of cancer.

Drug combination delays worsening of disease in women with recurrent ovarian cancer
September 10, 2014

Researchers from the Susan F. Smith Center for Women’s Cancers at Dana-Farber report that for some women with recurrent ovarian cancer, a new drug combination has been found to stall the progression of the disease.

Study finds big benefit in breast cancer drug (New York Times)

September 29, 2014

Dr. Harold Burstein commented on a study of Perjeta, a drug used to treat advanced breast cancer that had unprecedented success in prolonging lives.

Targeted treatments provide more options, better outcomes for cancer patients (Taunton Gazette)
October 01, 2014

Dr. Rachel Freedman commented on targeted treatments – those that attack a specific characteristic of a cancer strain – becoming the norm in breast cancer care.

Panel Calls for More Research in Advanced Breast Cancer (MedPageToday)
September 26, 2014

Dr. Eric Winer served as chair for a panel that developed the second international guidelines for management of advanced breast cancer.


PD-L1 Positivity Confers Worse Outcomes in Non–Clear Cell RCC (CancerNetwork)
September 22, 2014

Dr. Toni Choueiri led a study that found patients with non–clear cell renal cell carcinoma, PD-L1 positivity is associated with worse clinical outcomes, including a shorter overall survival and time to recurrence.


Holding your breath for cancer treatment (Portland Tribune)
September 22, 2014

Dr. Jay Harris proposed a breath-holding technique that reduces radiation to the heart during left-sided breast cancer treatment.

Should Women Remove Breasts and Ovaries Because of Future Cancer Risk? (
September 15, 2014

Dr. Harold Burstein commented on a study that found there was no evidence that surgery lowered the risk of death compared to more conservative lumpectomy and radiation.


End-of-life Care Preferences: A Promising Target for Reducing Racial Disparities in Terminal Cancer Care (
September 12, 2014

Shannon Harrington, PhD, participated in a study showing a patient's race and ethnicity dramatically influenced their preferences about the care they receive at the end of their lives.


Dana-Farber's Mammography Van(44)

October 02, 2014

MGH Charlestown Healthcare Center

Dana-Farber's Mammography Van brings state-of-the-art breast cancer screening to the women of Greater Boston. To learn more or schedule an appointment, please call 617-632-1974.

Mindfulness Meditation with Elana Rosenbaum, MS, LICSW

October 02, 2014

11:30 AM - 1:00 PM

Smith 330, Stoneman Patient Services Suite

 Presented by the Leonard P. Zakim Center for Integrative Therapies

Mindfulness is a way to pay attention to the present moment in a way that fosters love, kindness and self-care. Join us in practicing three different meditations, all of which can be useful in daily life to soothe mind and body. No prior experience is necessary--only a willingness to be present. Patients, family members, caregivers and staff are welcome.

Registration required. For more information and to register, please contact the Zakim Center at 617-632-3322 or at


Post-Transplant Telephone Support Group

October 02, 2014

3:00 PM - 4:00 PM


This  support group provides a place for patients currently 1-2 years post-allogenic stem-cell transplant to share the impact of experiences, feelings and challenges associated with the post-transplant phase of treatment.

Registration is required.  Please contact Tammy Weitzman, LICSW at 617-632-4353 to register.


  • Patient referral information, clinical resources and more.

  • Make an Appointment

    For adults:

    For children:

    Or complete the online form.

  • Clinical Trials

    Search current cancer clinical trials at Dana-Farber.

  • How to Help

    Yawkey Center for Cancer Care entrance 

    There are many ways to support Dana-Farber and the Jimmy Fund.

    give now button 
  • Top-ranked

    • U.S. News Best Hospitals Cancer 2014-2015 logo    U.S. News Best Children's Hospitals Cancer 2014-2015 logo 

    Top-ranked cancer center in New England for adults — #1 in the nation for children's cancer

  • Dana-Farber Blog

    Insight Blog screenshot 

    Insight features the latest in cancer care and research news from Dana-Farber.
    Read the blog

  • Dana-Farber eNewsletter

    Dana-Farber Spotlight 

    Stay current on the latest news by signing up for Spotlight, our email newsletter.
    View current issue
    Subscribe now